Abstract:
PURPOSE: A novel compound is provided to suppress triple reuptake by blocking serotonin, norepinephrine, and dopamine. CONSTITUTION: A compound selected among (1S,3aR,9bS)-1-phenyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole derivatives and pharmaceutically acceptable salts thereof is denoted by chemical formula 1. The compound is selected among (1S,3aR,9bS)-9-chloro-1-phenyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole, (1S,3aR,9bS)-8-chloro-1-phenyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole, (1S,3aR,9bS)-7-chloro-1-phenyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole, (1S,3aR,9bS)-7,8-dichloro-1-phenyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole, and pharmaceutically acceptable salts thereof. A pharmaceutical composition for preventing and treating depression contains the compound as an active ingredient.
Abstract:
PURPOSE: A phenylpyrazolyl methyl-2-(4-substituted piperidine-1-yl)acetamide derivative as a calcium ion channel modulator is provided to be used as an agent for preventing and treating heart diseases or pain. CONSTITUTION: A phenylpyrazolyl methyl-2-(4-substituted piperidine-1-yl)acetamide derivative is denoted by chemical formula 1. An agent for preventing and treating heart diseases or an agent for relieving chronic and acute pain contains the compound of chemical formula 1 as an active ingredient.
Abstract:
PURPOSE: A pyrazolyl piperazine compound with a pharmaceutical activity to a calcium channel and a pharmaceutical composition containing the same are provided to be used as a pharmaceutical composition for preventing or treating diseases of brain diseases, heart diseases, cancer, and pain. CONSTITUTION: A pyrazolyl piperazine compound is denoted by chemical formula 1. The compound of chemical formula 1 is prepared by binding piperazine compounds of chemical formula 2 and chloride compounds of chemical formula 3 under the presence of a base at 20-30 Deg. C. The base includes an organic base such as an amine-based base and an inorganic base. The reaction solvent is dichloromethane, tetrahydrofurane(THF), dimethyl formamide(DMF), dimethyl aceteamide(DMAC), and dioxane. A pharmaceutical composition for preventing brain diseases, cancer, heart diseases, or pain contains the compound of chemical formula 1.
Abstract:
본 발명은 T-형 칼슘 채널에 대한 활성을 갖는 1-(4-치환-1,4-디아제판-1-일)에탄온 화합물, 상기 화합물의 제조방법, 그리고 상기 화합물을 유효성분으로 포함하는 약학조성물에 관한 것이다. 본 발명의 신규 1-(4-치환-1,4-디아제판-1-일)에탄온 화합물 또는 약학적으로 허용 가능한 이의 염은 T-형 칼슘 채널에 대한 길항작용을 가지므로 간질, 고혈압 등의 뇌질환 치료제, 협심증 등의 심장질환 치료제, 만성 통증, 신경성 통증 등의 통증질환 치료제, 또는 항암제로 유용하다.
Abstract:
PURPOSE: A diphenylpropanoyl compound having T-type calcium channel activity is provided to ensure antagonism to a T-type calcium channel and to be used as a therapeutic agent and anticancer agent. CONSTITUTION: A diphenylpropanoyl is denoted by chemical formula 1. A pharmaceutical composition for preventing and treating hypertension, angina, chronic pain, neurogenic pain or cancer contains a compound of chemical formula 1 as an active ingredient. A method for preparing the compound of chemical formula 1 comprises a step of binding a compound of chemical formula 2 with a compound of chemical formula 3.